Today’s AI Top Pick: WAY

8/7/2026 · Bullish Consensus Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured weekly model accuracy · WAY68%28 resolved forecasts · 90d window · verify →

Today's pick · Bullish Consensus Reliable BullishWAYBUY NOW8.6 / 108/7/2026

Waystar (WAY) is the cleanest 'everything lines up' setup in this cohort. Every single forecast timeframe is meaningfully positive — 4h fc_short/mid/long +11.9%/+21.34%/+25.28%, 1d +14.94%/+26.33%/+21.86%, and 1wk +5.61%/+41.17%/+42.01% — with bullish_prob 1.0 and near_term_bullish 1.0. Multi-timeframe agreement this uniform (no negative forecast anywhere, on any horizon) is rare in the pool; most peers (FUTU, MNSO, BILI, ACM) have at least one timeframe with a negative short-horizon forecast. Drawdowns are shallow (4h -2.22%, 1d -4.69%, 1wk -9.42%) yet position-in-range is not maxed out (1d 69.17%, 1wk 69.12%), so we're buying strength but not chasing a blowoff. Fundamentals are top-decile for this list: fundamental_score 8, recom 1.16 (nearly unanimous Buy), targetUpsidePct 42.5%, fwdPe 12.44 (well below its trailing 33.28), peg 0.81, salesYoY +19.23%, epsNextY +12.63%, and profitMargin 11.18% with 82.33% institutional ownership. Debt/equity 0.37 is conservative for a healthcare-tech name. The YTD drawdown of −28.64% means the tape has already washed out weak hands, and the reset-plus-turn is exactly the pattern the screen was built to catch. Critically, the news tape is a tailwind, not a landmine. On Aug 3, Zacks upgraded WAY to Buy, and comparable-value coverage (WAY vs. ADSK) explicitly frames it as the cheaper play — this is a fresh, dated positive catalyst arriving right as the multi-timeframe forecast turns constructive. Contrast this with TCOM (China OTA regulatory curbs), FUTU (HK SFC freezing HK$125M in client assets — even if 'not under investigation,' it's a headline overhang), CRM (fourth layoff round in a year), NCNO (CEO/CFO insider selling into weakness), and TMDX (margins down, trials delayed, UBS PT cut) — all of which have material tape/thesis frictions WAY does not. Why today and not wait? The 1d forecast short window (+14.94%) is nearly as strong as the mid, meaning the model expects the move to start immediately, and the shallow 4.69% daily drawdown means you're not paying a premium — a pullback to $22.50 would just be normal noise. Waiting for a deeper pullback likely means missing the entry given the upgrade momentum. Full-conviction Buy today.

Entry zone

$23.00–$23.50 (current $23.37, add on any dip to $22.80)

Stop loss

$21.40 (below the 21-bar daily drawdown floor, ~8.5% risk)

First target

$26.50 (+13%, aligns with 1d fc_short/mid blend)

Longer target

$32.00–$33.00 (+37–41%, aligns with 1wk fc_mid +41.17% and 42.5% analyst target upside)

Risks

Short float 9.95% is elevated — a bad print could accelerate downside via short covering unwind
ROE only 3.77% and profit margin 11.18% mean valuation (fwdPe 12.44) leaves little room for guidance misses
Healthcare IT names have been sold hard in 2026 (perfYtd -28.64%, perfYear -31.24%) — sector re-rating risk persists
1wk position-in-range 69.12% is not deeply oversold; a broader market pullback could drag it to $21 quickly
Instant-liquidity risk on a $4.48B mid-cap — spreads widen fast in risk-off tape

Honorable mentions

NICEMulti-timeframe all positive with a monster 1wk forecast (+52%/+76%) and weekly position only 39.61% (not extended). fwdPe 7.64, peg 0.95, D/E 0.02 — pristine balance sheet. Q2 print just landed with 'undervalued value stock' coverage. Slight ding: recom 2.0 (weakest in the top tier).

MNSOCheapest peg in the entire list (0.17), recom 1.17, salesYoY +30.5%, fwdPe 7.86. 4h/1d forecasts are enormous (+44/+56/+49 and +15/+44/+44). Weekly position 22.73% means room to run. Held back only by 4h being extended (pos 87.56) and a weekly fc_short slightly negative (-1.12%).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	WAY	BUY NOW	8.6	All timeframes positive, fresh Zacks Buy upgrade, fund_score 8, near_term 1.0 — cleanest setup in the pool.
2	NICE	BUY NOW	8.2	1wk forecast +52/+76%, pos 39.61% not extended, fwdPe 7.64, D/E 0.02 — value + momentum combo.
3	MNSO	BUY NOW	8.0	Peg 0.17, recom 1.17, salesYoY +30.5%, huge 4h/1d forecasts, weekly pos 22.73% leaves room.
4	EPAM	BUY NOW	7.8	Massive multi-tf forecasts (1wk +59/+99), pos 45.7 mid-range, fwdPe 6.57, near_term 1.0 — outsized reward if it lands.
5	BILI	BUY NOW	7.4	Peg 0.54, 4h/1d fc +27/+40/+47 and +17/+35/+26, targetUpside 53.8%, weekly pos 23.34%.
6	ACM	BUY NOW	7.1	1d fc +17/+34/+27, ROE 27.71%, Lisbon airport win, recom 1.38 — solid industrials setup.
7	TMDX	BUY PULLBACK	6.9	4h/1d forecasts huge (+27/+22/+68 and +23/+42/+41) but pos 100 on 4h and 'margins down/trials delayed' headline is a caution.
8	MMS	BUY NOW	6.8	fwdPe 6.43, targetUpside 80%, 4h/1d/1wk forecasts all positive, Q3 EPS beat — deep value with turn.
9	STN	BUY PULLBACK	6.7	1d fc +5/+23/+27 but pos 99.53 on 1d — extended; wait for a pullback.
10	FIGR	BUY NOW	6.6	4h fc +41/+40/+44 and dd -15.81% — reset-and-turn setup; Bernstein PT raise to $70. Missing fundamentals limit conviction.
11	TRMB	BUY PULLBACK	6.3	4h pos 92.42 extended into Aug 12 earnings; forecast is modest. Better after the print.
12	ONON	BUY PULLBACK	6.2	Aug 11 earnings; 1wk fc_mid -15.87% is a red flag; wait for print.
13	TCOM	BUY PULLBACK	6.0	1d fc +15/+31/+28 and pos 15 on 4h — great entry — but China OTA regulatory curbs are a fresh overhang.
14	PDD	BUY PULLBACK	5.9	Extended (4h pos 94.32, 1d 91.78) and 4h fc short only +11%; don't chase, wait for a pullback.
15	CRM	WAIT	5.7	Positions 93+ on 4h/1d, forecast tepid (+3.56/+6.56 on 4h), and fresh SF layoff headline dampens sentiment.
16	FUTU	WAIT	5.6	1wk forecasts negative (-4.78/-18.09/-10.93) and HK SFC HK$125M asset freeze is an overhang despite denial.
17	KVYO	BUY PULLBACK	5.4	Strong forecasts (+9/+26/+37 on 4h) and near_term 0.8, but Benchmark downgrade today and PE 789 make sizing small.
18	BR	WAIT	5.3	Earnings beat and PT raise but pos 96.25 on 1d and 1wk fc negative — already priced in.
19	MLCO	BUY PULLBACK	5.3	1wk fc +35/+53 is big and peg 0.35 attractive, but profit margin 4.33% and 4h fc only +12% short — needs patience.
20	PEGA	BUY PULLBACK	5.1	4h/1d forecasts massive (+30/+48/+59 and +35/+48/+32) but pos 51-73 and short float 17.79% — volatile.
21	MORN	WAIT	4.8	4h fc negative (-8/-5/-1.93) and 1d/1wk pos ~100 — chased already.
22	EFX	WAIT	4.6	Forecasts modest (+4/+14/+13 on 1d), fundamental_score only 4.25, and legal settlement headlines noise.
23	NCNO	AVOID	4.4	Insider selling triple-headline the same day, PE 156, profit margin 2.17% — screen passes but tape is telling.
24	EXE	WAIT	4.3	1wk forecasts negative across all horizons (-3.67/-5.43/-3.46) and epsNextY -4.44%.
25	TME	WAIT	4.2	4h fc massive (+38/+55/+59) but peg 4.42 and near_term only 0.4 — inconsistent.
26	TRI	WAIT	4.1	1wk fc all negative (-8.81/-5.87/+5.11) and pos 100 across timeframes — fully priced.
27	SE	WAIT	3.5	bullish_prob only 0.4, near_term 0, 4h fc_short -10.99% — the tape is fading before Q2 print.
28	ETOR	AVOID	3.4	1d fc mid -4.77%, deep drawdown -13.36%, missing weekly data — no confirmation.
29	DSGX	AVOID	3.2	4h fc all negative (-8.61/-3.65/-1.3), pos 100 across all TFs — classic top.
30	LRN	AVOID	3.0	1wk fc -0.7/-15.51/-11.83 and pos 0 on 1d/1wk — trend broken.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord